HALO logo
halo search icon
SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc.
SLS · NAS

SELLAS Life Sciences Group, Inc.

US$7.56

Price Arrow-1.41 (-15.719%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig Candle (Realtime)HALO AllHALO Earnings MomentumHALO MomentumHALO Price MomentumRecent Earnings upgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

SELLAS Life Sciences Group, Inc. Overview

SLS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About SLS

icon

Telephone

1.646.200.5278

icon

Address

Suite 2503, 7 Times Square, Times Square Tower, New York, NY 10036

Description

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SLS Price Chart

Key Stats

Market Cap

US$1.67B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.39 - 9.1

Trade Value (12mth)

US$4,895,455.00

1 week

26.69%

1 month

87.66%

YTD

106.21%

1 year

409.66%

All time high

590585.00

Key Fundamentals

EPS 3 yr Growth

-88.40%

EBITDA Margin

0.00%

Operating Cashflow

-$28m

Free Cash Flow Return

-69.90%

ROIC

-66.10%

Interest Coverage

0.00

Quick Ratio

10.70

Other Data

Shares Outstanding (Fully Diluted)

172m

HALO Sector

Healthcare

Next Company Report Date

25-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

SLS Announcements

Latest Announcements

DateAnnouncements
13 May 26
13 May 26
13 May 26
13 May 26
13 May 26

SLS Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-1.34-0.5-0.25locklocklock
EPS (Fully Diluted)
$locklocklocklock-1.34-0.5-0.25locklocklock
Growth
%locklocklocklock36.962.551.2locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of SELLAS Life Sciences Group, Inc. (SLS:NAS)?
Halo FAQ
The current share price of SELLAS Life Sciences Group, Inc. (SLS:NAS) is USD$7.56.
What is the 52-week high share price for SELLAS Life Sciences Group, Inc. (SLS:NAS)?
Halo FAQ
The 52-week high share price for SELLAS Life Sciences Group, Inc. (SLS:NAS) is USD$9.10.
What is the 52-week low share price for SELLAS Life Sciences Group, Inc. (SLS:NAS)?
Halo FAQ
The 52-week low share price for SELLAS Life Sciences Group, Inc. (SLS:NAS) is USD$1.39.
What is the dividend yield for SELLAS Life Sciences Group, Inc. (SLS:NAS)?
Halo FAQ
SELLAS Life Sciences Group, Inc. (SLS:NAS) does not pay a dividend.
What was SELLAS Life Sciences Group, Inc. (SLS:NAS) last dividend payment?
Halo FAQ
SELLAS Life Sciences Group, Inc. (SLS:NAS) does not pay a dividend.
What is the franking level for SELLAS Life Sciences Group, Inc. (SLS:NAS)?
Halo FAQ
SELLAS Life Sciences Group, Inc. (SLS:NAS) has a franking level of 0.00%.
In which sector is SELLAS Life Sciences Group, Inc. (SLS:NAS) classified?
Halo FAQ
SELLAS Life Sciences Group, Inc. (SLS:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.